Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309724 · ClinicalTrials.gov registry record · NA
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT01309724 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 92 participants.
The verdict
NCT01309724, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
Inadequate identification of and subsequent delayed therapy for patients with hypoperfusion (including hypovolemia, congestive heart failure and sepsis) is a common problem faced by physicians and intensivists caring for critically ill patients. Bedside clinical assessment is notoriously inaccurate in diagnosing complex etiologies of hemodynamic disturbances and in deciding on the appropriate therapy. Invasive techniques which are often required to guide diagnosis and therapy have significant risks associated with them, are costly, and are time consuming. New technology has been developed that allows for instantaneous, noninvasive monitoring of key hemodynamic parameters, like stroke volume, peak velocity and cardiac output. This new technology has the potential to improve recognition of the etiology of hemodynamic disturbances and assist the clinician in optimizing therapy based on changes in hemodynamic parameters. There is significant potential for this to be translated into improved outcomes in critically ill patients, but this has never been studied.
Interventions
- OTHER USCOM-guided fluid administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01309724
The ClinicalTrials.gov registry entry for NCT01309724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which USCOM-guided fluid administration is the first listed.
NCT01309724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01309724 about?
NCT01309724 is a clinical study titled "Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients". Inadequate identification of and subsequent delayed therapy for patients with hypoperfusion (including hypovolemia, congestive heart failure and sepsis) is a common problem faced by physicians and intensivists caring for critically ill patients. Bedside clinical assessment is notoriously inaccurate ...
What is the current status of trial NCT01309724?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2010-01. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01309724?
The interventions under investigation include: USCOM-guided fluid administration (OTHER).
Who is sponsoring clinical trial NCT01309724?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.